Documentos de Júnior J.B.S. | REDI

Regresar

Mostrando 5 resultados de: 5

Filtros aplicados

Área de conocimiento: "Epidemiología"

Subtipo de publicación

Publisher

BMC Medicine(1)

Nature Communications(1)

PLoS Medicine(1)

The Lancet Infectious Diseases(1)

The Lancet Regional Health - Americas(1)

Área temáticas

Medicina y salud(5)

Enfermedades(3)

Medicina forense; incidencia de enfermedades(2)

Problemas sociales y servicios a grupos(2)

Farmacología y terapéutica(1)

Área de conocimiento

Salud Pública(2)

Inmunología(1)

Año de Publicación

Origen

Palabras Claves

EFFECTIVENESS(1)

Inactivated vaccine(1)

CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study

Abstract: Background: More doses of CoronaVac have been administered worldwide than any other COVID-19 vaccine

Palabras claves:

covid-19, Inactivated vaccine, pregnant women, SARS-COV-2, Vaccine effectiveness

Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Pinto Júnior E.P., Rodrigues L.C., Werneck G.L., Wong K.L.M.

Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study

Abstract: Background AU Brazil: and Scotland have used mRNA boosters in their respective : populations since S

Palabras claves:

Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Katikireddi S.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Robertson C., Rudan I., Sanchez M., Shah S.A., Sheikh A., Werneck G.L.

Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study

Abstract: Background: Aging influences COVID-19 severity and response to vaccination, but previous vaccine eff

Palabras claves:

CoronaVac, covid-19, EFFECTIVENESS, Vaccine, Vaxzevria

Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Barros J.V., Flores-Ortiz R.J., Ichihara M.Y.T., Júnior J.B.S., Machado T.M., Mauricio L. Barreto, Oliveira V.D.A., Penna G.O., Pescarini J.M., Werneck G.L.

Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period

Abstract: Although severe COVID-19 in children is rare, they may develop multisystem inflammatory syndrome, lo

Palabras claves:

Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Florentino P.T.V., Jantsch A.G., Júnior J.B.S., Mauricio L. Barreto, Oliveira V.D.A., Paixão E.S., Pearce N., Penna G.O., Rodrigues L.C., Werneck G.L.

Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study

Abstract: Background: Little is known about vaccine effectiveness over time among adolescents, especially agai

Palabras claves:

Agrawal U., Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Florentino P.T.V., Grange Z., Júnior J.B.S., Mauricio L. Barreto, McCowan C., Millington T., Paixão E.S., Pearce N., Penna G.O., Ritchie L.D., Robertson C., Rudan I., Sheikh A., Simpson C.R., Sullivan C., Vital Katikireddi S., Werneck G.L.